Biological Sample Collection Kits Market Segmentation:
Product
The swabs segment in the biological sample collection kits market is expected to register rapid revenue growth during the forecast period. This is due to an increase in the use of swabs, which cover a broad array of diagnostic applications, especially infectious disease testing. This is reinforced by the growing need for test swabs. The Panbio COVID-19 Antigen Self-Test launched by Abbott in July 2021 in India was based largely on swabs demand during the pandemic. This indicates their continued importance and adoption during the forecast period.
Application
The diagnostics segment is projected to contribute around 68% of the biological sample collection kits market share during the forecast period owing to early diagnosis and accurate disease detection. The increasing incidence of chronic diseases, coupled with the global trend towards prevention-based healthcare, is positively influencing demand for diagnostic sample collection kits. For example, in March 2023, Cue Health launched a new range of home-based diagnostic kits compatible with iOS and Android smartphones, enhancing convenience and leading growth for this segment.
Our in-depth analysis of the biological sample collection kits market includes the following segments:
|
Product |
|
|
Application |
|
|
Site of Collection |
|
